Basel, Switzerland, May 4th 2017 -- CIS Pharma presents its ADC drug carrier technology at Swiss Biotech Day 2017, scheduled for 14:10 during the Emerging Companies Streams. CIS Pharma ADC [...]
Bubendorf, Switzerland, December 2016 -- CIS Pharma welcomes Dr. Christophe Thommen, who will lead the research team as the new head of research and laboratory operations. Christophe is an expert [...]
Bubendorf, Switzerland October 2016 - CIS Pharma’s novel solubilization strategy for hydrophobic drugs has successfully reached the proof of concept phase. The Cellophil® Smart Polymer technology platform creates water-soluble formulations [...]
Bubendorf, Switzerland, September 2016 -- CIS Pharma has concluded the development of a novel contact lens coating technology based on the Cellophil® Smart Polymer platform. The technology has been shown [...]
Bubendorf, Switzerland, January 2016 -- Proof of concept studies at NBE Therapeutics demonstrated conjugation of CIS Pharma’s Cellophil® Smart Polymer drug carrier to antibodies. Consequently, different linkers were evaluated for [...]
Bubendorf, Switzerland, November 2015 -- CIS Pharma is expanding its Cellophil® Smart Polymer platform with new bio-inspired derivatives. The derivatives are used as building blocks for the development of a [...]
Bubendorf, Switzerland, September 2015 -- CIS Pharma has engaged in a research program to develop a new technology platform that creates water-soluble formulations of highly hydrophobic drugs. The approach comprises [...]
Bubendorf, Switzerland, April 2015 -- CIS Pharma welcomes Davide Panighetti, who reinforces the research team as the new synthesis chemist. Davide’s skills will boost the team working on proprietary drug [...]
Bubendorf, Switzerland, January 2015 -- CIS Pharma has taken a strategic decision to extend its activity into the field of cancer treatments. The defined objective is to improve the potency [...]